Lapatinib Completed Phase 1 Trials for Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00462956GW572016 In Patients With Advanced Or Metastatic Breast Cancer
NCT00790816Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
NCT00996762A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
NCT00371488GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer